0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gallium-68"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,750USDGBP
From
EUR$4,750USDGBP
Radiopharmaceutical Market - Product Thumbnail Image

Radiopharmaceutical Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
Radiotheranostics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Radiotheranostics Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
EUR$3,599USDGBP
From
EUR$4,949USDGBP
Loading Indicator

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases. Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more